Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Oxandrolone
Drug ID BADD_D01634
Description A synthetic hormone with anabolic and androgenic properties.
Indications and Usage Use to promote weight gain after weight loss following extensive surgery.
Marketing Status approved; investigational
ATC Code A14AA08
DrugBank ID DB00621
KEGG ID D00462
MeSH ID D010074
PubChem ID 5878
TTD Drug ID D0U3GL
NDC Product Code 49884-301; 0245-0271; 0245-0272; 64181-0003; 63629-7603; 55486-1570; 62991-2699; 65129-1066; 51552-1579; 58159-046; 49884-302
UNII 7H6TM3CT4L
Synonyms Oxandrolone | Oxandrin | SC-11585 | SC 11585 | SC11585 | Anavar
Chemical Information
Molecular Formula C19H30O3
CAS Registry Number 53-39-4
SMILES CC12CCC3C(C1CCC2(C)O)CCC4C3(COC(=O)C4)C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acne23.02.01.001--Not Available
Agitation19.06.02.001; 17.02.05.012--
Alanine aminotransferase13.03.04.002--Not Available
Aspartate aminotransferase13.03.04.008--Not Available
Azoospermia21.03.03.001--
Bladder irritation20.02.02.020--Not Available
Blood bilirubin increased13.03.04.018--
Blood calcium increased13.11.01.003--Not Available
Blood chloride increased13.11.01.005--Not Available
Blood creatine phosphokinase increased13.04.01.001--
Blood creatinine increased13.13.01.004--
Blood gonadotrophin decreased13.10.03.001--Not Available
Blood potassium increased13.11.01.011--Not Available
Bromosulphthalein test abnormal13.03.04.021--Not Available
Chronic obstructive pulmonary disease22.03.01.007--Not Available
Clitoral engorgement21.08.02.006--Not Available
Death08.04.01.001--
Depression19.15.01.001--
Dysphonia22.12.03.006; 19.19.03.002; 17.02.08.004--
Electrolyte imbalance14.05.01.002--Not Available
Enlarged clitoris05.05.01.004; 21.08.02.001--Not Available
Epididymitis21.09.02.001; 11.01.19.005--Not Available
Epiphyses premature fusion15.02.02.001; 05.05.03.002--Not Available
Erection increased21.03.01.004; 19.08.04.002--Not Available
Fluid retention20.01.02.003; 14.05.06.002--Not Available
Glucose tolerance decreased13.02.02.004--Not Available
Gynaecomastia21.05.04.003; 05.05.02.003--
Haemoglobin13.01.05.018--Not Available
Hepatic necrosis09.01.07.002--
Hepatic neoplasm16.07.03.001; 09.04.03.001--Not Available
The 1th Page    1 2    Next   Last    Total 2 Pages